MAPT and Alzheimer disease: In addition, it was found that the expression level of miR-26b in the cerebrospinal fluid of AD patients was significantly increased, and the up-regulation of miR-26b increased tau phosphorylation and neuronal cell apoptosis, promoting the occurrence and development of AD [17].